Powered by Q1Group LLC
Education and Decision Support Tools for the Medicare Community


July 2018 Formularies Updates: Fifty-Eight (58) Medications Added to Medicare Plan Drug Lists

Category: Monthly Formulary Changes
Published on 2018-07-13 14:48:12


The July, 2018 Medicare Part D plan formulary data (or drug lists) includes the addition of 81 new National Drug Codes (NDCs) to the Medicare Part D program.  These NDCs represent 58 different drugs, many with multiple strengths.

New Generic Drugs Introduced: See our article https://Q1News.com/700.html for highlights of the new generics.

New Brand-Name Drugs Introduced
In addition, 14 new brand-name drugs, some with multiple strengths, were added to Medicare Part D plan formularies.  These drugs include, BEVYXXA®, BONJESTA®, FIASP®, GLATOPA®, HAEGARDA®, LONHALA MAGNAIR®, NOCTIVA®, OZEMPIC®, PLIAGLIS®, RHOPRESSA®, SYMFI LO®, TYDEMY®, and XHANCE®.

What is the NDC?
The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: https://Q1FAQ.com/155.html

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 81 new NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 5
New Delivery Form and Strength 4
New Drug 13
New Drug and Strength 21
New Manufacturer 10
New Manufacturer and Delivery Form
3
New Manufacturer and Strength 7
New Manufacturer, Strength and Delivery Form
1
New Packaging 2
New Strength 15
Total New NDCs 81

Reminder: (1) Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan. (2) Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

The following chart details the first 81 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Code (NDC) or Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) to see the details of how this drug is covered by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name Notes
59148001971 ABILIFY MAINTENA ER 400 MG SUSER VIAL New Delivery Form
00024592410 ADMELOG 100 UNIT/ML VIAL [Humalog] New Drug and Strength
00024592505 ADMELOG SOLOSTAR 100 UNIT/ML INSULN PEN [Humalog KwikPen] New Drug and Strength
00002764001 ALIMTA 100 MG VIAL New Strength
64125013601 BENZTROPINE MES 0.5 MG Tablet [Cogentin] New Manufacturer
69853020201 BEVYXXA 40 MG CAPSULE New Drug and Strength
69853020101 BEVYXXA 80 MG CAPSULE New Drug and Strength
55494012060 BONJESTA ER 20-20 MG TABLET New Drug
23594012501 CEFACLOR 125 MG/5 ML SUSPEN [Ceclor] New Manufacturer
23594025001 CEFACLOR 250 MG/5 ML SUSPEN [Ceclor] New Manufacturer
23594037501 CEFACLOR 375 MG/5 ML SUSPEN [Ceclor] New Manufacturer
00310008839 DALIRESP 250 MCG TABLET New Strength
58468004101 FABRAZYME 5 MG VIAL New Strength
00169320111 FIASP 100 UNIT/ML VIAL New Drug
70199000632 FURADANTIN 25 MG/5 ML SUSP Oral Suspension New Manufacturer
00049005460 GEODON 40 MG CAPSULE New Strength
00781325089 GLATOPA 40 MG/ML SYRINGE New Manufacturer and Strength
63833082802 HAEGARDA 2,000 UNIT VIAL New Drug and Strength
63833082902 HAEGARDA 3,000 UNIT VIAL New Drug and Strength
45802014464 HYDROCORT-PRAMOXINE 1%-1% CREAM/APPL [Zone A] New Drug
55111068309 IBUPROFEN 600 MG ORAL TABLET New Manufacturer
55111068409 IBUPROFEN 800 MG ORAL TABLET New Manufacturer
00078073461 ILARIS 150 MG/ML VIAL New Delivery Form
57962001428 IMBRUVICA 140 MG TABLET New Delivery Form
57962028028 IMBRUVICA 280 MG TABLET New Delivery Form and Strength
57962042028 IMBRUVICA 420 MG TABLET New Delivery Form and Strength
57962056028 IMBRUVICA 560 MG TABLET New Delivery Form and Strength
57962007028 IMBRUVICA 70 MG CAPSULE New Strength
00085113301 INTRON A 25 MILLION UNIT/2.5ML New Strength
00006308001 ISENTRESS HD 600 MG TABLET New Strength
00093807316 KELNOR 1-50 TABLET [Zovia 1/50E] New Drug
69102013710 LAMOTRIGINE TAB START KT-ORANG DS PK [Subvenite] New Drug and Strength
69102035911 LAMOTRIGINE TAB START KT-GREEN DS PK [Subvenite] New Drug and Strength
69102063909 LAMOTRIGINE TAB START KIT-BLUE DS PK [Subvenite] New Drug and Strength
00093300893 LANSOPRAZOLE ODT 15 MG TABLET RAP DR [Prevacid] New Delivery Form
00093300993 LANSOPRAZOLE ODT 30 MG TABLET RAP DR [Prevacid] New Delivery Form
00143955801 LEVOLEUCOVORIN 50 MG VIAL [Fusilev] New Manufacturer and Strength
63402020100 LONHALA MAGNAIR 25 MCG STARTER VIAL-NEB New Drug
64011030103 MAKENA 275 MG/1.1 ML AUTO INJCT New Delivery Form and Strength
69238103106 MELODETTA 24 FE CHEWABLE TAB [Minastrin] New Drug
00378815577 METHYLPHENIDATE ER 18 MG TAB [Concerta] New Drug and Strength
00378815677 METHYLPHENIDATE ER 27 MG TAB [Concerta] New Drug and Strength
00378815777 METHYLPHENIDATE ER 36 MG TAB [Concerta] New Drug and Strength
00378815877 METHYLPHENIDATE ER 54 MG TAB [Concerta] New Drug and Strength
65293001410 MINOCIN 100 MG VIAL New Manufacturer and Delivery Form
54766010245 NAFTIN 2% CREAM New Manufacturer and Delivery Form
54766077245 NAFTIN 2% GEL New Manufacturer and Strength
00074327490 NIASPAN ER 750 MG TABLET [Slo-Niacin] New Strength
71758010655 NOCTIVA 0.83 MCG/0.1 ML SPRAY New Drug and Strength
71758010755 NOCTIVA 1.66 MCG/0.1 ML SPRAY New Drug and Strength
66658012060 ORFADIN 20 MG CAPSULE New Strength
50458019406 ORTHO MICRONOR 0.35 MG TABLET [Sharobel 28-Day] New Strength
50458025106 ORTHO TRI-CYCLEN LO TABLET [Trinessa Lo] New Packaging
00169413212 OZEMPIC 0.25-0.5 MG DOSE PEN New Drug and Strength
00169413602 OZEMPIC 1 MG DOSE PEN New Drug and Strength
00143951301 PALONOSETRON 0.25 MG/2 ML VIAL [Aloxi] New Drug and Strength
63323094205 PALONOSETRON 0.25 MG/5 ML VIAL [Aloxi] New Drug and Strength
64406001601 PLEGRIDY SYRINGE STARTER PACK New Packaging
51672530502 PLIAGLIS 7%-7% CREAM (g) New Drug
75987010004 PROCYSBI DR 25 MG CAPSULE SPR New Manufacturer
75987010108 PROCYSBI DR 75 MG CAPSULE SPR New Manufacturer
70727049725 RHOPRESSA 0.02% OPHTH SOLUTION Drops New Drug
00054040713 RITONAVIR 100 MG TABLET [Norvir] New Drug
00641621725 ROBAXIN 1,000 MG/10 ML VIAL New Drug
69660020291 RUBRACA 250 MG TABLET New Strength
89141012301 SOLTAMOX 20 MG/10 ML SOLN Solution New Manufacturer and Strength
57894042101 SYLVANT 400 MG VIAL New Strength
49502042593 SYMFI LO 400-300-300 MG TABLET New Drug
60574411301 SYNAGIS 100 MG/1 ML VIAL New Strength
69238110603 TIAGABINE HCL 12 MG TABLET [Gabitril] New Manufacturer and Strength
69238110703 TIAGABINE HCL 16 MG TABLET [Gabitril] New Manufacturer and Strength
24208081425 TIMOPTIC-XE 0.25% EYE GEL-SOLN SOL-GEL New Manufacturer and Delivery Form
17478029010 TOBRAMYCIN 0.3% EYE DROPS [Tobrex] New Manufacturer
70121116801 TRIAMCINOLONE 200 MG/5 ML VIAL [Triesence] New Manufacturer, Strength and Delivery Form
17772010330 TROKENDI XR 100 MG CAPSULE ER 24H New Strength
68180090413 TYDEMY TABLET New Drug
71143037501 XHANCE 93 MCG NASAL SPRAY AER BR.ACT New Drug
00078067515 ZOFRAN 4 MG TABLET New Manufacturer and Strength
89141044430 ZUPLENZ 4 MG SOLUBLE FILM New Drug and Strength
89141044830 ZUPLENZ 8 MG SOLUBLE FILM New Drug and Strength
57894019506 ZYTIGA 500 MG TABLET New Strength

Our online Formulary Browser and Drug Finder
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.






Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs




Ask a Pharmacist*
Have questions about your medication?

» Answers to Your Medication Questions, Free!
Available Monday - Friday
8am to 5pm MST
*A free service included with your no cost drug discount card.




Tips & Disclaimers
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDP-Compare.com and MA-Compare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.